Back
Speaker illustration

Professor Ursula Rauch

Charite University Hospital, Berlin (Germany)

Articles

Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision?<sup> </sup>

Date: 8 April 2022

Journal: European Heart Journal

Access
Like
Thumbnail

Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction

Date: 19 April 2019

Journal: European Heart Journal

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources